Leptin levels in patients with systemic lupus erythematosus inversely correlate with regulatory T cell frequency

Lupus

Volumn 26, Issue 13, 2017, Pages 1401-1406

  Wang, X ^a   Qiao, Y ^a   Yang, L ^a   Song, S ^a   Han, Y ^a   Tian, Y ^a   Ding, M ^a   Jin, H ^a   Shao, F ^a   Liu, A ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

leptin; regulatory T cells; Systemic lupus erythematosus (SLE)

Indexed keywords

LEPTIN;

ADULT; ARTICLE; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; EX VIVO STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERLEPTINEMIA; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CELL CULTURE; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADULT; CELLS, CULTURED; FEMALE; HUMANS; LEPTIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY;

EID: 85030773758     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203317703497     Document Type: Article

References (26)

1. La Cava A,. T-regulatory cells in systemic lupus erythematosus. Lupus 2008; 17: 421-425.
2. Liu A, La Cava A,. Epigenetic dysregulation in systemic lupus erythematosus. Autoimmunity 2014; 47: 215-219.
3. La Cava A, Matarese G,. The weight of leptin in immunity. Nat Rev Immunol 2004; 4: 371-379.
4. De Rosa V, Procaccini C, Calì G, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007; 26: 241-255.
5. Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, et al. Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int 2002; 22: 138-141.
6. Santos FM, Telles RW, Lanna CC, et al. Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus. Lupus 2017; 26: 10-16.
7. Matarese G, Carrieri PB, La Cava A, et al. Leptin increase in multiple sclerosis associates with reduced number of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A 2005; 102: 5150-5155.
8. Lourenço EV, Liu A, Matarese G, La Cava A,. Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation. Proc Natl Acad Sci U S A 2016; 113: 10637-10642.
9. Hutcheson J, Ye Y, Han J, et al. Resistin as a potential marker of renal disease in lupus nephritis. Clin Exp Immunol 2015; 179: 435-443.
10. McMahon M, Skaggs BJ, Sahakian L, et al. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis 2011; 70: 1619-1624.
11. Liu Y, Liu A, Iikuni N, Xu H, Shi FD, La Cava A,. Regulatory CD4+ T cells promote B cell anergy in murine lupus. J Immunol 2014; 192: 4069-4073.
12. Procaccini C, De Rosa V, Galgani M, et al. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 2010; 33: 929-941.
13. Amarilyo G, Iikuni N, Liu A, Matarese G, La Cava A,. Leptin enhances availability of apoptotic cell-derived self-antigen in systemic lupus erythematosus. PLoS One 2014; 9: e112826-e112826.
14. Liu Y, Yu Y, Matarese G, La Cava A,. Cutting edge: Fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus. J Immunol 2012; 188: 2070-2073.
15. Li HM, Zhang TP, Leng RX, Li XP, Li XM, Pan HF,. Plasma/serum leptin levels in patients with systemic lupus erythematosus: A meta-analysis. Arch Med Res 2015; 46: 551-556.
16. Wisłowska M, Rok M, Stȩpień K, Kuklo-Kowalska A,. Serum leptin in systemic lupus erythematosus. Rheumatol Int 2008; 28: 467-473.
17. Vadacca M, Zardi EM, Margiotta D, et al. Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus. Intern Emerg Med 2013; 8: 705-712.
18. Toussirot É Michel F, Binda D, Dumoulin G,. The role of leptin in the pathophysiology of rheumatoid arthritis. Life Sci 2015; 140: 29-36.
19. Deng J, Liu Y, Yang M, et al. Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response. Arthritis Rheum 2012; 64: 3564-3573.
20. Zarkesh-Esfahani H, Pockley G, Metcalfe RA, et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 2001; 167: 4593-4599.
21. Lord GM, Matarese G, Howard JK, Bloom SR, Lechler RI,. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol 2002; 72: 330-338.
22. Liu A, Zhang W, Tian X, Zhang X, Zhang F, Zeng X,. Prevalence, risk factors and outcome of digital gangrene in 2684 lupus patients. Lupus 2009; 18: 1112-1118.
23. Payne GA, Tune JD, Knudson JD,. Leptin-induced endothelial dysfunction: A target for therapeutic intervention. Curr Pharm Des 2014; 20: 603-608.
24. Fernández-Nebro A, Rúa-Figueroa Í López- Longo FJ, et al. Cardiovascular events in systemic lupus erythematosus: A nationwide study in Spain from the RELESSER Registry. Medicine (Baltimore) 2015; 94: e1183-e1183.
25. von Spee-Mayer C, Siegert E, Abdirama D, et al. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann Rheum Dis 2016; 75: 1407-1415.
26. Matarese G, De Rosa V, La Cava A,. Regulatory CD4 T cells: Sensing the environment. Trends Immunol 2008; 29: 12-17.